Table 2.
Initial Breast Reconstruction Surgery (n = 30 Breasts)
| Characteristic | n | % | |
|---|---|---|---|
| Indication for mastectomy | Invasive cancer | 17 | 56.7 |
| DCIS | 4 | 13.3 | |
| Risk-reducing | 9 | 30 | |
| Timing of reconstruction | Immediate | 30 | 100 |
| Delayed | 0 | 0 | |
| Initial prosthesis type | Tissue expander | 16 | 53.3 |
| Direct to implant | 14 | 46.7 | |
| Placement of prosthesis | Sub-pectoral | 25 | 83.3 |
| Pre-pectoral | 5 | 16.7 | |
| Coverage of implant | Synthetic* | 17 | 56.7 |
| Biologic† | 6 | 20.0 | |
| Autologous‡ | 5 | 16.7 | |
| None | 2 | 6.7 | |
| Initial prosthesis size (g/mL) | Mean | 350 | NA |
| Median | 335 | NA | |
| Range | 100–650 | NA | |
| Unknown§ | 4 | 13.3 |
*Synthetic mesh included TiLOOP Bra, TiLOOP Bra Pocket, SERI Surgical Scaffold, and TIGR Matrix.
†Biologic mesh included the following Acellular Dermal Matrices—Veritas, Strattice, FlexHD, and Biodesign.
‡Autologous included lipodermal flap.
§Not retrieved from review of medical record.